Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)-Reference-Cited by-同舟云学术

Comparison of the clinical outcomes of hematologic malignancies after myeloablative haploidentical transplantation with G-CSF/ATG and posttransplant cyclophosphamide: results from the Chinese Bone Marrow Transplantation Registry Group (CBMTRG)

Published:2019-08-14 Issue:4 Volume:63 Page:571-581
ISSN:1674-7305
Container-title:Science China Life Sciences
language:en
Short-container-title:Sci. China Life Sci.

Author:

Tang Feifei,Xu Yajing,Chen Huiren,Xu Lanping,Zhang Xiaohui,Wang Yu,Liu Qifa,Wu Depei,Huang Xiaojun

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology

Link

http://link.springer.com/content/pdf/10.1007/s11427-019-9594-7.pdf

Reference35 articles.

1. Apperley, J., Niederwieser, D., Huang, X., Nagler, A., Fuchs, E., Szer, J., and Kodera, Y. (2016). Reprint of: haploidentical hematopoietic stem cell transplantation: a global overview comparing asia, the european union, and the united states. Biol Blood Marrow Transplant 22, S15–S18.

2. Armand, P., Kim, H.T., Logan, B.R., Wang, Z., Alyea, E.P., Kalaycio, M.E., Maziarz, R.T., Antin, J.H., Soiffer, R.J., Weisdorf, D.J., et al. (2014). Validation and refinement of the disease risk index for allogeneic stem cell transplantation. Blood 123, 3664–3671.

3. Bacigalupo, A., Dominietto, A., Ghiso, A., Di Grazia, C., Lamparelli, T., Gualandi, F., Bregante, S., Van Lint, M.T., Geroldi, S., Luchetti, S., et al. (2015). Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update. Bone Marrow Transplant 50, S37–S39.

4. Bashey, A., Zhang, X., Jackson, K., Brown, S., Ridgeway, M., Solh, M., Morris, L.E., Holland, H.K., and Solomon, S.R. (2016). Comparison of outcomes of hematopoietic cell transplants from T-replete haploidentical donors using post-transplantation cyclophosphamide with 10 of 10 HLA-A, -B, -C, -DRB1, and -DQB1 allele-matched unrelated donors and HLA-identical sibling donors: a multivariable analysis including disease risk index. Biol Blood Marrow Transplant 22, 125–133.

5. Bashey, A., Zhang, X., Sizemore, C.A., Manion, K., Brown, S., Holland, H. K., Morris, L.E., and Solomon, S.R. (2013). T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol 31, 1310–1316.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triplet therapy with gilteritinib, venetoclax, and azacitidine for relapsed/refractory FLT3 acute myeloid leukemia;Leukemia Research;2024-10

2. Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party;Cancer;2024-05-17

3. Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial;BMC Medicine;2024-02-27

4. Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt‐related transcription factor 1 mutation: A single‐center retrospective analysis;Hematological Oncology;2024-02-17

5. The effect of haploidentical hematopoietic stem cell transplantation on comutations based on next‐generation sequencing in adult acute myeloid leukemia patients with the FLT3‐ITD mutation;Hematological Oncology;2023-06-04